|
Display additional annotations [+]
|
| |
Fig. 5. Xhas2 and Xversican affect cardiogenesis in combination with XHAPLN3. (A, B) Ventral views with anterior toward the left. (C–F) Lateral views with anterior toward the left and dorsal upwards. (A′–F′) Transverse sections of panels A–F embryos taken at respective positions of red lines. (A′–D′) Dorsal upwards. (E′, F′) Dorsal toward the left. so, somite; PCM, precardiac mesoderm; EC, endocardium; MC, myocardium. Scale bars in panels A–F and A′–F′ indicate 0.5 mm and 0.1 mm, respectively. |
|
Display additional annotations [+]
|
| |
Fig. 9. Loss of XHAPLN3 and Xhas2 effect around precardiac region. Tbx5 (A–C), myocardin (D–F), GATA4 (G–I), Sox17α (J–L), Hex (M–O), Xlfli (P–R), SCL (S–U), and Xversican (V–X) mRNA expressions at stage 23. Ventral views with anterior toward the left. Scale bars indicate 0.5 mm. The number of photo-presenting phenotype per total number of injected embryos is indicated at the upper right of each panel. |
